Pharma Mergers and Acquisitions

Author: Turacoz Group
November 28, 2017

Mergers and acquisitions (M&As) refer to consolidation of companies or assets. Merger means combining two companies into one, while acquisition refers to taking over of one company by the other one. In pharmaceutical world, mergers and acquisitions are quite common. According to the insights, M&As help the pharmaceutical companies in achieving their goals easily by acquiring it, instead of making it. Moreover, the companies with products which are soon to be off-patent also seek for companies with high revenue potential to acquire. Moreover, the expenditure involved in research and development has also attracted the investors to merge with or acquire other companies.

Indian pharmaceutical industry, which is known for its highly skilled core players and low-cost manufacturing, has also been highly influenced by M&As. Many domestic and cross-border M&As have been witnessed by the Indian Pharma companies. The major reasons which have drawn the attention of Indian pharma companies towards M&As are presented in Figure 1.

Figure 1: Major reasons of Pharma Mergers and Acquisition in India

Some of the major M&A Deals that took place in India recently (2015-2017) are:

  1. Mergers of Ranbaxy and SunPharmaceuticals
  2. Acquisition of Primal Healthcare by Abbott
  3. Acquisition of Ranbaxy by DaiichiSankyo
  4. Acquisition of US-based Gavin by Lupin Ltd.
  5. Acquisition of Russian Biocom by Lupin Ltd.
  6. Acquisition of Taro by Sun Pharmaceuticals
  7. Acquisition of UCB by Dr Reddy’s Laboratories
  8. Acquisition of Beta Pharma by DrReddy’s Laboratories
  9. Acquisition of Elder Pharma by Torrent Pharma

It is apparent that such M&As have become essential for the pharmaceutical industry to grow. Moreover, the trend does not seem to slow down due to their necessity to meet the expenditures. However, the loss of expected R&D and thoroughness associated with M&As warrants development of comprehensive guidelines for successful M&As.

Turacoz Healthcare Solutions keeps a tab of the latest healthcare update and studies Pharma mergers and acquisitions in detail. We extend our services in assisting pharmaceutical companies by providing them end-to-end writing support in both the publication and regulatory arena.

Tags:

You Might Also Like

  • Top Benefits of Using Academic Research Writing Services

    “Write the paper as though no editor will ever see it … then let a good editor make sure everyone

  • World Thyroid Day 2025: How AI Is Revolutionizing Thyroid Health

    World Thyroid Day invites us to appreciate the tiny, butterfly-shaped gland with a big job in managing our body’s energy,

  • How AI is redefining content creation in pharma — And why humans are still the drivers of trust

    In an era where speed, efficiency, and personalization have become imperatives, Artificial Intelligence (AI) — particularly machine learning, AI algorithms,

  • World Thalassemia Day 2025: Giving a Voice to the Global Patient Community

    Every 8 May, World Thalassemia Day shines an international spotlight on the millions of people living with this inherited genetic disorder.

  • Decoding Ovarian Cancer Symptoms: Communicating the Silent Signs

    Ovarian cancer remains one of the most challenging gynaecologic malignancies, often referred to as a “silent killer” due to its subtle onset and late-stage diagnosis.1 In 2022, 324,603 women worldwide were diagnosed with ovarian cancer.

  • 4 Ways in Which HEOR is Transforming Healthcare with RWE

    The healthcare landscape is being reshaped at an unprecedented pace, powered by sophisticated data analytics, emerging technologies, and the escalating

  • The Role of HEOR in Payer Decisions to Switch from Originators to Biosimilars

    Biosimilars—biologic medicines that are highly similar to FDA-approved originator biologics—offer a cost-effective alternative without compromising clinical efficacy.1,2 Since the first

  • Content’s Industrial Revolution: Shaping the Future of Pharma

    Communications In a rapidly evolving digital ecosystem, the pharmaceutical industry’s relationship with content is undergoing a seismic shift. At the

  • Health Journalism: Combating Misinformation with Accuracy

    By Turacoz Healthcare Solutions | World Liver Day 2025 In a world where social media dominates wellness discussions, liver health

  • Patient Voices Matter: How Patient-reported Outcomes Are Redefining Market Access

    The healthcare industry is experiencing a paradigm shift as patient voices take center stage in drug development and approval processes.

Newsletter

Stay informed with the latest trends, insights, and updates in medical communications—download our newsletter now.

partner with us

Partner with Turacoz to bring science to life through strategic and evidence-based communication.

Partner with Us